GE HealthCare Technologies Inc.

GEHC Acquires Intelerad to Boost Cloud-First, AI Imaging Capabilities

GE HealthCare completes the $2.3B Intelerad deal to expand AI-driven imaging, boost recurring revenues and strengthen its cloud-first healthcare platform.

Source: Zacks Mar 20, 2026

Stryker Investors Weigh Cyberattack Recovery As CEO Joins GE HealthCare Board

Stryker CEO Kevin Lobo has been appointed to the Board of Directors of GE HealthCare. The appointment links leadership at two large medical technology companies with global reach. Stryker, traded as NYSE:SYK, enters this leadership development with its shares at $345.81. Over the past 3 years the stock shows a total return of 30.7%, and over 5 years a total return of 55.7%, which gives investors some historical context for how the company has rewarded long term holders. For investors...

Source: Simply Wall St. Mar 19, 2026

GEHC & Springbok Collaborate on MRI Muscle Analysis for Sports

GE HealthCare teams with Springbok to pair MRI tech with AI muscle analytics, aiming to redefine how muscle health is measured and visualized.

Source: Zacks Mar 19, 2026

Hologic's Women's Health Index Flags Alarming Gaps in STI Screening

HOLX's Global Women's Health Index shows STI testing stagnates at 10%, leaving nearly 2 billion women at risk despite gains in other screenings.

Source: Zacks Mar 19, 2026

Should You Hold or Sell HOLX Stock as It Nears the End of Public Phase?

Hologic nears its $76 buyout price as Diagnostics faces headwinds, tariffs hurt, and the stock trades at a sector premium.

Source: Zacks Mar 18, 2026

GE HealthCare Says Middle East Exposure Under 5% at Barclays Conference, Highlights Supply Chain Moves

GE HealthCare Technologies (NASDAQ:GEHC) executives told investors at a Barclays conference that the company’s direct exposure to the Middle East is “definitely less than 5%” of overall business, while management is prioritizing employee safety and business continuity amid regional disruptions. Bar

Source: MarketBeat Mar 17, 2026